Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia

Detalhes bibliográficos
Autor(a) principal: Kirizawa, Jociele M. [UNESP]
Data de Publicação: 2020
Outros Autores: Garner, David M. [UNESP], Valenti, Vitor E. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1007/s00520-020-05629-0
http://hdl.handle.net/11449/199197
Resumo: Introduction: Considering that heart rate (HR) autonomic control is impaired in cancer and subsequent respiratory effort may overload the heart, we aimed to evaluate the effect of a respiratory physical therapy session on HR autonomic regulation in children with leukemia so as to confirm its safety. Methods: We selected children with leukemia (n = 10) and healthy children (n = 11), which were submitted to a session of respiratory physical therapy. We used Spiron Kids (NCS, Brazil), Children’s Voldyne (HUDSON RCI, USA), and Shaker (NCS, Brazil) as respiratory devices. The respiratory exercise protocols were founded on three standardized protocols. HR variability (HRV) was analyzed before, in the first minute and 5 to 10 min after intervention. Results: We recognized no change between rest and recovery from intervention in HRV (rMSSD—square root mean square of the differences between adjacent normal R-R intervals)—Control: p = 0.8111, Leukemia: p = 0.1197, among groups: p = 0.6574; SD1—standard deviation from instantaneous beat-to-beat variability—Control: p = 0.8111, Leukemia: p = 0.131, among groups: p = 0.6556; 0V—with no variation (3 equal symbols, for example (2,2,2)—Control: p = 0.3679, Leukemia: p = 0.3553, among groups: p = 0.7421); 2UV—with two variations to the contrary (the three symbols form a peak or a valley, for instance (3,5,3)—Control: p = 0.3679, Leukemia: p = 0.2359, among groups: p = 0.4007). HF—high frequency component, range 0.15 to 0.4 Hz—decreased 0 to 1 min after intervention in the leukemia group (p = 0.0303) and no change was observed in the control group between rest versus recovery from intervention (p = 0.9761). No significant change was reported in HF between groups (p = 0.8700). Two leukemia subjects treated with vincristine presented different HRV responses to the intervention group. Conclusion: A respiratory physical therapy session did not significantly change autonomic control of HR in children with leukemia. Yet, clinicians should be mindful of subjects undergoing treatment with vincristine.
id UNSP_06e2dd2a6f5bd73c4e3126fdbd2ee644
oai_identifier_str oai:repositorio.unesp.br:11449/199197
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Impact of respiratory physical therapy on heart rate autonomic control in children with leukemiaAutonomic nervous systemCardiovascular systemHeart rateLeukemiaPhysiotherapyIntroduction: Considering that heart rate (HR) autonomic control is impaired in cancer and subsequent respiratory effort may overload the heart, we aimed to evaluate the effect of a respiratory physical therapy session on HR autonomic regulation in children with leukemia so as to confirm its safety. Methods: We selected children with leukemia (n = 10) and healthy children (n = 11), which were submitted to a session of respiratory physical therapy. We used Spiron Kids (NCS, Brazil), Children’s Voldyne (HUDSON RCI, USA), and Shaker (NCS, Brazil) as respiratory devices. The respiratory exercise protocols were founded on three standardized protocols. HR variability (HRV) was analyzed before, in the first minute and 5 to 10 min after intervention. Results: We recognized no change between rest and recovery from intervention in HRV (rMSSD—square root mean square of the differences between adjacent normal R-R intervals)—Control: p = 0.8111, Leukemia: p = 0.1197, among groups: p = 0.6574; SD1—standard deviation from instantaneous beat-to-beat variability—Control: p = 0.8111, Leukemia: p = 0.131, among groups: p = 0.6556; 0V—with no variation (3 equal symbols, for example (2,2,2)—Control: p = 0.3679, Leukemia: p = 0.3553, among groups: p = 0.7421); 2UV—with two variations to the contrary (the three symbols form a peak or a valley, for instance (3,5,3)—Control: p = 0.3679, Leukemia: p = 0.2359, among groups: p = 0.4007). HF—high frequency component, range 0.15 to 0.4 Hz—decreased 0 to 1 min after intervention in the leukemia group (p = 0.0303) and no change was observed in the control group between rest versus recovery from intervention (p = 0.9761). No significant change was reported in HF between groups (p = 0.8700). Two leukemia subjects treated with vincristine presented different HRV responses to the intervention group. Conclusion: A respiratory physical therapy session did not significantly change autonomic control of HR in children with leukemia. Yet, clinicians should be mindful of subjects undergoing treatment with vincristine.Autonomic Nervous System Center Sao Paulo State University UNESP, Av. Hygino Muzzi Filho, 737. Mirante, 17.525-900—MaríliaCardiorespiratory Research Group Department of Biological and Medical Sciences Faculty of Health and Life Sciences Oxford Brookes University, Headington Campus, Gipsy LaneAutonomic Nervous System Center Sao Paulo State University UNESP, Av. Hygino Muzzi Filho, 737. Mirante, 17.525-900—MaríliaUniversidade Estadual Paulista (Unesp)Oxford Brookes UniversityKirizawa, Jociele M. [UNESP]Garner, David M. [UNESP]Valenti, Vitor E. [UNESP]2020-12-12T01:33:21Z2020-12-12T01:33:21Z2020-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1007/s00520-020-05629-0Supportive Care in Cancer.1433-73390941-4355http://hdl.handle.net/11449/19919710.1007/s00520-020-05629-02-s2.0-85088875754Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengSupportive Care in Cancerinfo:eu-repo/semantics/openAccess2021-10-23T04:45:21Zoai:repositorio.unesp.br:11449/199197Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T04:45:21Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
title Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
spellingShingle Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
Kirizawa, Jociele M. [UNESP]
Autonomic nervous system
Cardiovascular system
Heart rate
Leukemia
Physiotherapy
title_short Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
title_full Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
title_fullStr Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
title_full_unstemmed Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
title_sort Impact of respiratory physical therapy on heart rate autonomic control in children with leukemia
author Kirizawa, Jociele M. [UNESP]
author_facet Kirizawa, Jociele M. [UNESP]
Garner, David M. [UNESP]
Valenti, Vitor E. [UNESP]
author_role author
author2 Garner, David M. [UNESP]
Valenti, Vitor E. [UNESP]
author2_role author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Oxford Brookes University
dc.contributor.author.fl_str_mv Kirizawa, Jociele M. [UNESP]
Garner, David M. [UNESP]
Valenti, Vitor E. [UNESP]
dc.subject.por.fl_str_mv Autonomic nervous system
Cardiovascular system
Heart rate
Leukemia
Physiotherapy
topic Autonomic nervous system
Cardiovascular system
Heart rate
Leukemia
Physiotherapy
description Introduction: Considering that heart rate (HR) autonomic control is impaired in cancer and subsequent respiratory effort may overload the heart, we aimed to evaluate the effect of a respiratory physical therapy session on HR autonomic regulation in children with leukemia so as to confirm its safety. Methods: We selected children with leukemia (n = 10) and healthy children (n = 11), which were submitted to a session of respiratory physical therapy. We used Spiron Kids (NCS, Brazil), Children’s Voldyne (HUDSON RCI, USA), and Shaker (NCS, Brazil) as respiratory devices. The respiratory exercise protocols were founded on three standardized protocols. HR variability (HRV) was analyzed before, in the first minute and 5 to 10 min after intervention. Results: We recognized no change between rest and recovery from intervention in HRV (rMSSD—square root mean square of the differences between adjacent normal R-R intervals)—Control: p = 0.8111, Leukemia: p = 0.1197, among groups: p = 0.6574; SD1—standard deviation from instantaneous beat-to-beat variability—Control: p = 0.8111, Leukemia: p = 0.131, among groups: p = 0.6556; 0V—with no variation (3 equal symbols, for example (2,2,2)—Control: p = 0.3679, Leukemia: p = 0.3553, among groups: p = 0.7421); 2UV—with two variations to the contrary (the three symbols form a peak or a valley, for instance (3,5,3)—Control: p = 0.3679, Leukemia: p = 0.2359, among groups: p = 0.4007). HF—high frequency component, range 0.15 to 0.4 Hz—decreased 0 to 1 min after intervention in the leukemia group (p = 0.0303) and no change was observed in the control group between rest versus recovery from intervention (p = 0.9761). No significant change was reported in HF between groups (p = 0.8700). Two leukemia subjects treated with vincristine presented different HRV responses to the intervention group. Conclusion: A respiratory physical therapy session did not significantly change autonomic control of HR in children with leukemia. Yet, clinicians should be mindful of subjects undergoing treatment with vincristine.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-12T01:33:21Z
2020-12-12T01:33:21Z
2020-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1007/s00520-020-05629-0
Supportive Care in Cancer.
1433-7339
0941-4355
http://hdl.handle.net/11449/199197
10.1007/s00520-020-05629-0
2-s2.0-85088875754
url http://dx.doi.org/10.1007/s00520-020-05629-0
http://hdl.handle.net/11449/199197
identifier_str_mv Supportive Care in Cancer.
1433-7339
0941-4355
10.1007/s00520-020-05629-0
2-s2.0-85088875754
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Supportive Care in Cancer
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799964400692494336